An international team of scientists, led by Raymond Stevens of the Bridge Institute at the USC Michelson Center for Convergent Bioscience, is investigating a protein in the brain that will likely be the target of improved obesity therapies. [1½ min read]
USC researchers issue a call to scientists to help them create the first comprehensive model of a cell that is central to diabetes, the pancreatic beta cell.
USC Michelson Center scientists are part of an international team developing new alternatives to easing pain in the midst of a national crisis.
A call for researchers to find convergent bioscience opportunities engenders an unexpected initiative, one that brings USC science and cinematic arts students together to find answers in biology.
With six high-profile papers published in the past seven months, biochemists in The Bridge@USC are poised to disrupt the future of pharmaceutical development and enable the advancement of personalized medicine.
Inspired to find answers by her grandfather’s heart disease, Tiffany Lian is conducting research on taste receptors that may benefit drug discovery and development.
USC Dornsife researchers are combining the best minds from the arts and sciences to create a virtual model of the human body as The Bridge@USC aims to catalyze a new era of biotech leadership in the Los Angeles area.
Valery Fokin will join top scientists in USC’s aim to be among the world’s preeminent institutions for convergent biomedical research.
